Richard A. Heyman sold Enliven Therapeutics ($ELVN) shares on the open market six times over the past year, totaling $413 thousand, with his latest sale on February 17, 2026. These $ELVN sales rank 6,871st among insiders. He also sold Oric Pharmaceuticals ($ORIC) shares twice for $80 thousand, most recently on January 16, 2026, ranking 9,868th for $ORIC sales. Heyman made no open market purchases. Among 11,678 insiders with sales, the average is $8.6 million across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1230 | $26.18 | 171,865.0000 | 62,093,795 | 0.71% | 0.00% |
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 19234 | $0.00 | 19,234.0000 | 62,093,795 | 9999.99% | 0.03% |
| Jan. 20, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 512 | $26.46 | 173,813.0000 | 62,093,795 | 0.29% | 0.00% |
| Jan. 20, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 718 | $26.96 | 173,095.0000 | 62,093,795 | 0.41% | 0.00% |
| Jan. 16, 2026 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | S | Common Stock | 3500 | $12.00 | 254,872.0000 | 98,953,331 | 1.35% | 0.00% |
| Jan. 16, 2026 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | S | Common Stock | 3200 | $12.00 | 254,872.0000 | 98,953,331 | 1.24% | 0.00% |
| Jan. 9, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 4285 | $25.00 | 148,780.0000 | 62,093,795 | 2.80% | 0.01% |
| Jan. 8, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1620 | $25.00 | 149,218.0000 | 62,093,795 | 1.07% | 0.00% |
| Jan. 8, 2026 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 8015 | $25.04 | 153,065.0000 | 62,093,795 | 4.98% | 0.01% |
| Jan. 2, 2026 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 98,953,331 | 9999.99% | 0.04% |
| Oct. 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | M | Common Stock | 31353 | $1.60 | 260,125.0000 | 98,953,331 | 13.70% | 0.03% |
| Oct. 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | M | Stock Option (right to buy) | 1447 | $0.00 | 52,253.0000 | 98,953,331 | 2.69% | 0.00% |
| Oct. 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | M | Stock Option (right to buy) | 18125 | $0.00 | 0.0000 | 98,953,331 | 100.00% | 0.02% |
| Oct. 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | M | Stock Option (right to buy) | 13228 | $0.00 | 33,700.0000 | 98,953,331 | 28.19% | 0.01% |
| Oct. 3, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | M | Common Stock | 1447 | $3.75 | 261,572.0000 | 98,953,331 | 0.56% | 0.00% |
| June 5, 2025 | PMV Pharmaceuticals, Inc. | $PMVP | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 33500 | $0.00 | 33,500.0000 | 51,933,604 | 9999.99% | 0.06% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 23014 | $0.00 | 23,014.0000 | 47,072,532 | 9999.99% | 0.05% |
| Jan. 2, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 69,727,940 | 9999.99% | 0.05% |
| Oct. 18, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 753 | $30.00 | 188,245.0000 | 48,267,458 | 0.40% | 0.00% |
| Oct. 18, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 817 | $30.00 | 188,245.0000 | 48,267,458 | 0.43% | 0.00% |
| Oct. 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $27.67 | 189,815.0000 | 48,267,458 | 0.66% | 0.00% |
| Oct. 4, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 2825 | $27.51 | 191,085.0000 | 48,267,458 | 1.46% | 0.01% |
| Oct. 1, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 518 | $27.54 | 193,910.0000 | 48,267,458 | 0.27% | 0.00% |
| Sept. 16, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $22.41 | 194,428.0000 | 35,546,215 | 0.65% | 0.00% |
| Aug. 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 620 | $23.70 | 195,698.0000 | 35,546,215 | 0.32% | 0.00% |
| Aug. 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 650 | $22.82 | 196,318.0000 | 35,546,215 | 0.33% | 0.00% |
| July 31, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1702 | $27.51 | 196,968.0000 | 35,546,215 | 0.86% | 0.00% |
| July 31, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 649 | $27.50 | 196,968.0000 | 35,546,215 | 0.33% | 0.00% |
| July 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $24.80 | 199,319.0000 | 35,546,215 | 0.63% | 0.00% |
| June 17, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $21.48 | 200,589.0000 | 35,546,215 | 0.63% | 0.00% |
| June 12, 2024 | Oric Pharmaceuticals, Inc. | $ORIC | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 25600 | $0.00 | 25,600.0000 | 51,450,848 | 9999.99% | 0.05% |
| June 6, 2024 | PMV Pharmaceuticals, Inc. | $PMVP | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 67500 | $0.00 | 67,500.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $23.74 | 201,859.0000 | 35,546,215 | 0.63% | 0.00% |
| April 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1190 | $19.94 | 203,209.0000 | 35,546,215 | 0.58% | 0.00% |
| April 11, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 649 | $25.00 | 203,129.0000 | 35,546,215 | 0.32% | 0.00% |
| April 11, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 5045 | $25.03 | 66,112.4250 | 35,546,215 | 7.09% | 0.01% |
| April 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 80 | $20.68 | 203,129.0000 | 35,546,215 | 0.04% | 0.00% |
| March 19, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $14.50 | 210,093.0000 | 35,546,215 | 0.60% | 0.00% |
| Feb. 15, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $17.42 | 211,363.0000 | 35,546,215 | 0.60% | 0.00% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 29205 | $0.00 | 29,205.0000 | 35,546,215 | 9999.99% | 0.08% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | A | Stock Option (right to buy) | 21043 | $0.00 | 21,043.0000 | 35,546,215 | 9999.99% | 0.06% |
| Jan. 30, 2024 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Not found | S | Common Stock | 1270 | $16.41 | 212,633.0000 | 35,546,215 | 0.59% | 0.00% |
| Dec. 21, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 7 | $13.00 | 214,071.0000 | 0 | 0.00% | 0.00% |
| Dec. 22, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 35 | $13.00 | 213,903.0000 | 0 | 0.02% | 0.00% |
| Dec. 21, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 6 | $13.00 | 213,938.0000 | 0 | 0.00% | 0.00% |
| Dec. 22, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 168 | $13.00 | 213,903.0000 | 0 | 0.08% | 0.00% |
| Dec. 19, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 255 | $13.00 | 216,229.0000 | 0 | 0.12% | 0.00% |
| Dec. 20, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 1915 | $13.02 | 214,119.0000 | 0 | 0.89% | 0.00% |
| Dec. 20, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | S | Common Stock | 2110 | $13.02 | 214,119.0000 | 0 | 0.98% | 0.00% |
| June 8, 2023 | PMV Pharmaceuticals, Inc. | $PMVP | Heyman Richard A. | Director | A | Stock Option (right to buy) | 21500 | $0.00 | 21,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | A | Stock Option (right to buy) | 34458 | $0.00 | 34,458.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | A | Common Stock | 31172 | $0.00 | 180,992.0000 | 0 | 20.81% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | A | Common Stock | 149820 | $0.00 | 180,992.0000 | 0 | 480.62% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | A | Common Stock | 37407 | $0.00 | 187,227.0000 | 0 | 24.97% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Heyman Richard A. | Director | A | Employee Stock Option (right to buy) | 20657 | $0.00 | 20,657.0000 | 0 | 9999.99% | 0.00% |